MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Therapeutic Efficacy of a Next-Generation 16-Contact Directional Deep Brain Stimulation System in Parkinson’s Disease

    F. Morgante, C. Matthies, S. Vinke, R. Schuurman, V. Visser-Vandewalle, A. Gharabaghi, V. Coenen, J. Fitzgerald, D. Pedrosa, A. Kühn, C. Mertz, L. Chen, R. Shivacharan, E. Goldberg (London, United Kingdom)

    Objective: We assessed the clinical efficacy and safety of a novel deep brain stimulation (DBS) system equipped with 16-contact directional leads in improving motor symptoms…
  • 2026 International Congress

    Video-Based Gait Analysis for Objective Assessment of Motor Severity and Surgical Outcome in Parkinson’s Disease: A Scalable Alternative to Subjective Rating

    Y. Samanci, E. Yildirim, B. Samanci, G. Kenangil, AF. Cangi, A. Zirh (Istanbul, Turkey)

    Objective: To evaluate the accuracy of a gait-focused video analysis model in predicting clinical scores and post-surgical improvement in Parkinson’s disease (PD) Background: The MDS-UPDRS…
  • 2026 International Congress

    Efficacy and Adverse Events of Tetrabenazine, Deutetrabenazine, and Valbenazine in Huntington’s Disease

    J. Patino, J. Pitton Rissardo, A. Fornari Caprara, A. Mcgarry, I. Walker, N. Rocha, A. Duker, E. Furr Stimming (Cincinnati, USA)

    Objective: To compare the efficacy and safety of tetrabenazine, deutetrabenazine, and valbenazine for chorea and neuropsychiatric outcomes in Huntington’s disease (HD). Background: Vesicular monoamine transporter…
  • 2026 International Congress

    Transcutaneous Spinal Cord Stimulation in Hereditary Spastic Paraplegias

    J. Sanderson, M. Davis, H. Farhadi, C. Moritz, F. Inanici (Seattle, USA)

    Objective: To assess transcutaneous spinal cord stimulation (tSCS) as a treatment for hereditary spastic paraplegias (HSPs). Background: Hereditary spastic paraplegias (HSPs) are genetic disorders characterized…
  • 2026 International Congress

    Integrating Transcriptomics and Morphological Profiling to Characterize GBA-Associated Parkinson’s Disease in Midbrain Organoids

    F. Nasta, E. Glaab, JC. Schwamborn (Esch-sur Alzette, Luxembourg)

    Objective: This study characterizes converging biological trends in GBA-associated Parkinson’s Disease by integrating transcriptomic profiling with exploratory image-based analysis of donor-matched midbrain organoids. Background: High-content…
  • 2026 International Congress

    Non-Motor Symptom Improvement as a Driver of Quality of Life after Subthalamic Stimulation in Symmetric Parkinson’s Disease

    ST. Jost, PA. Loehrer, K. Ashkan, A. Rizos, J. Krauss, E. Karst, A. Kosma, R. Biundo, J. Evans, V. Visser-Vandewalle, C. Nimsky, G. Fink, M. Silverdale, A. Fasano, P. Martinez-Martin, A. Antonini, P. Borghammer, L. Timmermann, K. Ray Chaudhuri, H. Dafsari (Cologne, Germany)

    Objective: To investigate non-motor outcomes in patients with symmetric vs. asymmetric motor symptoms following subthalamic stimulation (STN-DBS) in Parkinson’s disease (PD). Background: Motor asymmetry is…
  • 2026 International Congress

    The Impact of Demographic Factors on Skull Density Ratios in a Hawaii Cohort

    K. Thai, F. Gao, M. Morita, R. Shuman, M. Faouzi, E. Krening, M. Bruno (Honolulu, USA)

    Objective: To understand the impact of demographic factors on skull density ratio (SDR) in Hawai‘i patients. Background: SDR is a validated indicator of the ability…
  • 2026 International Congress

    When Muscles Relax but Symptoms Persist: A Case of Dysfunctional Sensory-Motor Cortical Integration in Botulinum Toxin-Resistant Blepharospasm

    VD. Tkachenko, MZ. Makoeva (Moscow, Russian Federation)

    Objective: To present a case of blepharospasm (BSP) with objective response to serial botulinum toxin injections but persistent subjective symptoms, highlighting the role of sensory…
  • 2026 International Congress

    Underestimation of Nighttime Sleep Symptoms in Isolated RBD is Associated with Increased Risk of Phenoconversion to Synucleinopathy: A North American Prodromal Synucleinopathy Consortium Study

    J. Ha, D. Bliwise, H. Dela Cruz, C. Xiong, T. Ferman, K. Kantarci, V. Lowe, S. Criswell, E. ST. Louis, D. Huddleston, A. Avidan, Y. Ju, M. Lim, M. Miglis, R. Postuma, A. Videnovic, B. Boeve, M. Howell, L. Trotti (Atlanta, USA)

    Objective: To determine whether mismatch between participant (PT) self-perceived and bed partner (BP)–reported sleep symptoms is associated with risk of phenoconversion to synucleinopathy. Background: Patients…
  • 2026 International Congress

    Regional Homogeneity in the Visual Network Mediates between Microbiota and Cognition in Parkinson’s Disease

    S. Monti, S. Cauzzo, E. Fiorenzato, F. Vianello, P. Mariotto, G. Baruzzo, B. Di Camillo, R. Manara, A. Bertoldo, A. Antonini (Padova, Italy)

    Objective: We study the role of spontaneous brain activity in the cross-talk between gut microbiota and cognition in PD. Background: Gut dysbiosis is a prevalent…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley